Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Litfulo™ (ritlecitinib) – New drug approval
June 23, 2023 - Pfizer announced the FDA approval of Litfulo (ritlecitinib), for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
